Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Armando Hernandez-Rey

Reproductive Endocrinology Coral Gables, FL Medical Doctor

NPI 1598723306 CMS profile 71584

2828 Coral Way, Suite 103, Coral Gables, FL 33145

Open in the dashboard

General payments

$28,264

180 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Armando Hernandez-Rey of Coral Gables, FL is reported in the CMS Open Payments database as having received $28,264 across 180 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Reproductive Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $603 19
2024 General $337 14
2023 General $847 17
2022 General $649 25
2021 General $6,207 32
2020 General $7,709 24
2019 General $11,913 49

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Armando Hernandez-Rey
  • Reproductive Endocrinology median
  • Middle half of Reproductive Endocrinology
  • National median

In program year 2025, general payments to Armando Hernandez-Rey were reported at $603. Among 986 Reproductive Endocrinology profiles paid that year, the median was $141 and the middle half received between $66 and $285.

Show as a table
Year Armando Hernandez-Rey Reproductive Endocrinology median Middle half National median
2019 $11,913 $196 $77–$425 $163
2020 $7,709 $81 $35–$182 $114
2021 $6,207 $102 $43–$247 $132
2022 $649 $139 $62–$303 $149
2023 $847 $141 $65–$285 $160
2024 $337 $144 $65–$302 $164
2025 $603 $141 $66–$285 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $23,684 54 payments
  2. Ferring Pharmaceuticals Inc. $2,279 71 payments
  3. Hologic, LLC $768 23 payments
  4. Myriad Women's Health, Inc. $444 1 payment
  5. CooperSurgical, Inc. $197 3 payments
  6. Astellas Pharma US Inc $127 1 payment
  7. EMD Serono, Inc. $113 6 payments
  8. Myovant Sciences Inc. $103 5 payments
  9. Astellas Pharma Global Development $102 1 payment
  10. Intuitive Surgical, Inc. $97 1 payment
  11. Other $350 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $21,000 11 payments
  2. Food and Beverage $5,151 158 payments
  3. Travel and Lodging $2,106 10 payments
  4. Education $7 1 payment
Products named General payments · program years 2019–2025
  1. Orilissa Endocrinology $10,535 24 payments
  2. ORIAHNN $8,972 15 payments
  3. ORILISSA Womens Health $2,229 15 payments
  4. INVOCELL $1,028 13 payments
  5. MENOPUR Reproductive Health $717 36 payments
  6. MENOPUR Reproductive Health $507 21 payments
  7. myRisk $444 1 payment
  8. ACESSA PROVU SYSTEM $379 10 payments
  9. Veozah $229 2 payments
  10. Aptima $228 4 payments
  11. Other $1,482 58 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

180 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record